Chemoinformaics analysis of 2-Methyl-1,3-pentadiene
Molecular Weight | 82.146 | nRot | 1 |
Heavy Atom Molecular Weight | 72.066 | nRig | 2 |
Exact Molecular Weight | 82.0782 | nRing | 0 |
Solubility: LogS | -1.655 | nHRing | 0 |
Solubility: LogP | 1.806 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 16 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 6 | No. of Aromatic Carbocycles | 0 |
nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 10 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 6 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
nHA | 0 | APOL | 16.6879 |
nHD | 0 | BPOL | 10.0321 |
QED | 0.425 |
Synth | 3.288 |
Natural Product Likeliness | 2.253 |
NR-PPAR-gamma | 0.004 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0 |
Pgp-sub | 0.002 |
HIA | 0.004 |
CACO-2 | -4.178 |
MDCK | 0.0000298 |
BBB | 0.992 |
PPB | 0.586028 |
VDSS | 1.231 |
FU | 0.613846 |
CYP1A2-inh | 0.836 |
CYP1A2-sub | 0.932 |
CYP2c19-inh | 0.121 |
CYP2c19-sub | 0.884 |
CYP2c9-inh | 0.023 |
CYP2c9-sub | 0.933 |
CYP2d6-inh | 0.065 |
CYP2d6-sub | 0.891 |
CYP3a4-inh | 0.014 |
CYP3a4-sub | 0.266 |
CL | 7.775 |
T12 | 0.773 |
hERG | 0.009 |
Ames | 0.059 |
ROA | 0.037 |
SkinSen | 0.851 |
Carcinogencity | 0.657 |
EI | 0.996 |
Respiratory | 0.768 |
NR-Aromatase | 0.021 |
Antiviral | No |
Prediction | 0.948376 |